medigraphic.com
ISSN 1560-4381 (Print)

2021, Number 4

<< Back Next >>

Correo Científico Médico 2021; 25 (4)

Clinical and nutritional behavior of the sarcopenic syndrome in elders integrated to elderly care programs

Carbó AY, Peña GM, Rivas CR, Niño ES, Jorge SY

Language: Spanish
References: 17
Page:
PDF size: 381.32 Kb.


ABSTRACT

Introduction: Sarcopenia is the loss of skeletal muscular mass and of relative functionality due to the age thataffects the functional independence, health and life quality. Presarcopenia is associated to the loss of muscular mass does without affecting strength.
Objective: To identify the clinical and nutritional behavior of the sarcopenic syndrome in elders from the Downtown Popular Council of Holguin city, Cuba.
Method: A cross-sectional study was carried out, in which 94 adults over 60 years participated, from both sexes, selected by means of an intentional sampling. Sarcopenia was determined using functional tests, skeletal muscle mass indexes and anthropometric indicators; nutritional mini-surveyswere applied and biochemical tracers were determined. Variance analysis were madeto compare the means of the 3 groups, and in case of p<0,05the multiple comparison of means was made with Benferronitest and T3 Dunett´s method. The Epidat 3.1 statistical program was used.
Results: The prevalence of sarcopenia was 13.8% and of presarcopenia was 35.1%, with a higher prevalence in the male sex (53.84%). Diabetes mellitus was an associated disease in 61.5% of patients and smoking was a risk factor in 18.08%. The means of body mass index, fat percentage and serum cholesterol levels were significantly higher in non-sarcopenic elderly people.
Conclusions: Sarcopenia and presarcopenia predominated in men, and non-sarcopenia prevailed in women. Sarcopenia was not related to either associated diseases or smoking. Patients with sarcopenia had no alterations in insulin resistance. It is recommended to study institutionalized elderly people who do not perform systematic physical activity.


REFERENCES

  1. Dent E, Morley JE, Cruz Jentoft AJ, Arai H, Kritchevsky SB, J Guralnik, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging.2018[citado 25/07/2020];22(10): 1148-1161.https://link.springer.com/article/10.1007%2Fs12603-018-1139-9

  2. Zuñiga R. Conceptos básicos sobre obesidad sarcopénica en el adulto mayor. RevClínEsc Med.2015 [citado 20/12/2019]; 5(3). Disponible en:https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=61423

  3. Zayas Somoza E, FundoraAlvarez V., Santana Porben S. Sobre las interrelaciones entre la Sarcopenia, el envejecimiento y la nutrición. RCAN.2018[citado18/05/2021];28(1):152-176. Disponible en: http://www.revalnutricion.sld.cu/index.php/rcan/article/view/550

  4. Barbosa‐Silva TG, Bielemann RM, González MC, Menezes AMB. Prevalence of Sarcopenia among community‐dwellingelderly of a medium‐sized South American city: Results of the COMO VAI? Study. J Cachexia Sarcopenia Muscle. 2016[citado 25/07/2021];7(2): 136-143.Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.12049

  5. Dhillon RJ, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017[citado 25/08/2020]; 33(1):17-26.https://www.sciencedirect.com/science/article/abs/pii/S0749069016300714?via%3Dihub

  6. Cuba. Ministerio de Salud Pública. Anuario estadístico de Cuba. La Habana: MINSAP; 2018

  7. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016[citado 27/01/2020]; 7(5):512-514.https://onlinelibrary.wiley.com/doi/10.1002/jcsm.12147

  8. Espinel Bermúdez MA, Sánchez García S, García Peña C, Trujillo X, Huerta Viera M, Granados García V, et al. Factores asociados a Sarcopenia en adultos mayores mexicanos: Encuesta Nacional de Salud y Nutrición. Rev Med Inst Mex Seguro Soc. 2018[citado 25/07/2020];56(Supl 1):46-53.Disponible en: https://www.medigraphic.com/pdfs/imss/im-2018/ims181g.pdf

  9. Céspedes Basteiro YC, Peña González M, Rodríguez Graña T. Exceso De Peso Y Sarcopenia en Ancianos Que Viven Sin Restricciones en La Comunidad. RCAN. 2018[citado 280/04/2020];28(1):67–81. Disponible en:http://www.revalnutricion.sld.cu/index.php/rcan/article/view/527

  10. Fernández Patty BV, Dominguez Alonso E, Vázquez Izada B, Acosta Cedeño A, Diaz Socorro C, Navarro Despaigne DA. Sarcopenia y factores relacionados en mujeres mayores de 40 años. Rev Cubana Endocrinol. 2020[citado 20/07/2021];31(3):1-11.Disponible en:https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=100636

  11. Rodríguez Rejón AI, Ruiz López MD, WandenBerghe C, Artacho R. Prevalence and Diagnosis of Sarcopenia in Residential Facilities: A Systematic Review. Adv Nutr. 2019 [citado 21/08/2020]; 10(1):51-58. Disponible en:https://academic.oup.com/advances/article/10/1/51/5298227?login=true

  12. Vergara Ortiz AL. Diagnóstico de Sarcopenia mediante determinación de velocidad de marcha e índice de masa musculas por método BIA, en adultos mayores del municipio Ayapango. Estado de México (Tesis).Ciudad de México. Universidad Autónoma del Estado de México; 2015.

  13. Rojas Bermúdez C,Buckcanan Vargas A, Benavides Jiménez G. Sarcopenia: abordaje integral del adulto mayor: Revisión de tema. Rev Méd Sinerg[citado 25/07/2021];4(5):24-34. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/194

  14. Sipilä S, Törmäkangas T, Sillanpää E, Aukee P, Kujala UM, Kovanen V, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle. 2020[citado 28/05/2021];11(3):698-709.Disponible en:https://onlinelibrary.wiley.com/doi/10.1002/jcsm.12547

  15. Lee D, Shook RP, Drenowatz C, Blair SN. Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. FutureScience OA. 2016[citado 25/08/2021];2(3).Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137918/

  16. Garza González EL, Gallegos Flores EA, Hernández Gutierrez J, Flores Monsivais JE. Biomarcadores moleculares en la predicción de sarcopenia. Rev Salud Pública Nutr. 2017[citado 27/01/2020];16(1):23-32.Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=74484

  17. Hernández-Rodríguez J, Arnold-Domínguez Y, Licea Puig ME. Sarcopenia y algunas de sus características más importantes. Rev Cubana Med Gen Integr. 2019[citado 02/05/2020]; 35(3):1-19. Disponible en:https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=94464




2020     |     www.medigraphic.com